ADAMTS13 and cancer: Results of the cohort of Pépin et al21 were similar, as cancer patients with VTE had mean ADAMTS‐13/VWF values of 0.36 (IQR 0.22‐0.49) and cancer patients without VTE had 0.44 (IQR 0.28‐0.57).